SCHEMBL9545809

SCHEMBL9545809

CNC1(c2ccc(Cl)c(Cl)c2)CCc2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 15/20 0.43
GRIN1 Q05586 3/20 0.43
GRIN2A Q12879 3/20 0.43
OPRK1 P41145 1/20 0.43
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
LMNA P02545 1/20 0.43
OPRM1 P35372 1/20 0.43
GRIN2B Q13224 1/20 0.43
CACNA1C Q13936 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
SLC6A3 Q01959 12/20 0.41
SLC6A2 P23975 3/20 0.40
KCNH2 Q12809 2/20 0.40
CYP2D6 P10635 1/20 0.39
KDM1A O60341 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7378848 0.94 SLC6A4 (0.46) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
SCHEMBL7546727 0.94 SLC6A4 (0.46) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
Hydrochloric Acid SCHEMBL7949501 0.93 SLC6A4 (0.45) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
SCHEMBL7948379 0.87 SLC6A4 (0.43) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
Mandelic Acid SCHEMBL5394925 0.81 SLC6A4 (0.38) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
SCHEMBL7949675 0.80 AKR1B1 (0.43) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
SCHEMBL7528171 0.72 GRIN1 (0.50) SLC6A4GRIN1GRIN2AOPRK1GRIN2D
SCHEMBL4784319 0.72 KDM1A (0.46) SLC6A4SLC6A3SLC6A2KDM1A
Hydrochloric Acid SCHEMBL7755304 0.71 KDM1A (0.45) SLC6A4OPRM1SLC6A3SLC6A2KCNH2
SCHEMBL9405484 0.69 SLC6A4 (0.43) SLC6A4SLC6A3SLC6A2KCNH2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993021917-A1 DOPAMINE AND NORADRENERGIC REUPTAKE INHIBITORS IN TREATMENT OF SCHIZOPHRENIA YALE UNIVERSITY (US) 1993-11-11 WO disclosed